Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma

• Published in: Molecular and cellular biochemistry Vol. 447; no. 1-2; pp. 125 - 136
• Main Authors: Rashad, Nearmeen M., El-Shal, Amal S., Shalaby, Sally M., Mohamed, Salem Y.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.10.2018; Springer; Springer Nature B.V
• Subjects: Adult; Biochemistry; Biological markers; Biomarkers; Biomarkers, Tumor - blood; Biomedical and Life Sciences; Carcinoma, Hepatocellular - blood; Cardiology; Case-Control Studies; Chronic infection; Cirrhosis; Diagnostic systems; Female; Health aspects; Hepatitis; Hepatitis C; Hepatitis C - blood; Hepatitis C virus; Hepatocellular carcinoma; Hepatology; Humans; Life Sciences; Liver; Liver cancer; Liver cirrhosis; Liver Cirrhosis - blood; Liver Neoplasms - blood; Lymph nodes; Male; Medical Biochemistry; Medical research; Metastases; Metastasis; MicroRNA; MicroRNAs; MicroRNAs - administration & dosage; MicroRNAs - blood; Middle Aged; miRNA; Oncology; Patients; Polymerase chain reaction; Regression analysis; Regulators; Ribonucleic acid; Risk factors; RNA; RNA, Neoplasm - blood; Viruses; Hepatocellular carcinoma; Chronic hepatitis C; Real-time-PCR; Hepatitis C virus; Liver cirrhosis; MicroRNAs
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/s11010-018-3298-8

Hepatitis C virus (HCV) infection remains the main risk factor for chronic hepatitis (CHC), liver cirrhosis, and hepatocellular carcinoma (HCC). Changes in microRNA (miRNA) profiles can be associated with HCV infection and may either favor or inhibit the virus and/or its complication. Moreover, miRNAs have emerged as key regulators of various cancers including HCC. The aim of this work was to investigate the potentail role of miRNA-27a and miRNA-18b expression levels as non-invasive predictive biomarkers of hepatitis C virus-associated HCC. Furthermore, we aimed to explore potential association of these miRNAs expressions with HCC clinicopathological features’ in Egyptian cases. This case control study included 200 participants [60 CHC patients, 39 post-HCV cirrhosis patients, 51 HCC cases], and 50 healthy volunteers. The serum miRNA-27a and miRNA-18b expression profiles were measured using quantitative real time-polymerase chain reaction ( qRT-PCR). miRNA-27a and miRNA-18b expression levels were significantly increased in post-hepatitis C cirrhosis cases compared to control and CHC groups. In HCC group, only miRNA-27a expression levels were significantly increased. Moreover, miRNA-27a and miRNA-18b expression levels were positively correlated with distant metastasis, Child–Pugh grade, and lymph node metastasis. Logistic regression analysis revealed that miRNA-27a expression was an independent predictor of cirrhosis among CHC. Receiver operating characteristic (ROC) analyses showed that miRNA-27a and miRNA-18b expression levels were useful biomarkers discriminating cirrhosis from CHC (AUC were 0.672 and 0.487, respectively), and in differentiating HCC from post-hepatitis C cirrhosis (AUC were 0.897 and 0.723, respectively). By combined ROC analysis, power of miRNA-27a and miRNA-18b expression levels as discriminator between HCC from post-hepatitis C cirrhosis was high (AUC = 0.0.821). Serum microRNA-27a and miRNA-18b expression levels are promising diagnostic and non-invasive biomarkers of CHC, post-CHC cirrhosis, and HCC.